However, fatigue can have many causes, so evaluation from a healthcare provider is recommended
Research goals: Metabolic & Weight Description AOD-9604 (CAS 221231-10-3) is a synthetic 16-amino-acid peptide corresponding to the C-terminal fragment of human growth hormone (hGH 177191) with an additional N-terminal tyrosine added to enhance stability
See below for important safety information
Manufacturing of this sterile product demands proper aseptic environment, well-functioned machines and compliance to good manufacturing practices to attain a high quality product
AOD-9604 primarily targets fat metabolism MOTS-c focuses on mitochondrial function and metabolic efficiency Tesamorelin increases physiologic growth hormone release and reduces visceral fat Semaglutide reduces appetite through GLP-1 signaling Tirzepatide combines GLP-1 and GIP receptor activation and currently delivers some of the most impressive weight-loss results seen in modern medicine Understanding these differences is essential when choosing the right therapy for weight loss, metabolic health, body composition, or long-term wellness goals
To learn more about vitamin injections in general, read our blog post on vitamin injections